Study limitation: Inter-JAKi comparisons are confounded by substantial differences in patient selection, timing of drug availability, and follow-up duration rather than true pharmacological differences | ReachRx
Real-world efficacy and safety profile of four JAK inhibitors in rheumatoid arthritis: a French single-center observational study
Study limitation reported by the research below: “Inter-JAKi comparisons are confounded by substantial differences in patient selection, timing of drug availability, and follow-up duration rather than true pharmacological differences.”
